Utilizing ClinGen gene-disease validity and dosage sensitivity curations to inform variant classification

Area of Science:

• Genomics
• Medical Genetics
• Bioinformatics

Background:

• Assessing gene-disease relationships and variant mechanisms is crucial for clinical relevance.
• The National Institutes of Health-funded Clinical Genome Resource (ClinGen) developed evaluation frameworks.
• These frameworks assess gene-disease validity and dosage sensitivity (haploinsufficiency, triplosensitivity).

Purpose of the Study:

• To describe the utilization of ClinGen's curation results.
• To inform the application of pathogenicity criteria for sequence and copy number variants.
• To guide genomic test development and filtering pipelines.

Main Methods:

• Application of ClinGen's gene-disease validity evaluation framework.
• Application of ClinGen's dosage sensitivity evaluation framework.
• Public dissemination of curated data via the ClinGen website.

Main Results:

• ClinGen provides robust frameworks for assessing gene-disease evidence.
• Curated data informs variant classification and pathogenicity assessments.
• Framework results guide the development of clinical genomic testing.

Conclusions:

• ClinGen's frameworks are essential for understanding gene-disease links and variant mechanisms.
• Publicly available data supports accurate clinical variant interpretation.
• These resources enhance the reliability of genomic medicine applications.